Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome

26 Jan 2022

Abstract excerpt

Frailty is an aging-related pathology, defined as a state of increased vulnerability to stressors, leading to a limited capacity to meet homeostatic demands. Extracellular microRNAs (miRNAs) were proposed as potential biomarkers of various disease conditions, including age-related pathologies. The primary objective of this study was to identify blood miRNAs that could serve as potential biomarkers and candidate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to Frailty in Older Adults
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35205276
DOI: 10.3390/genes13020231

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty SyndromePMID 35205276Read ↗

The Potential Role of miRNAs in Cognitive FrailtySemantic proximity Read ↗

Inflammatory Markers and Clinical Factors as Key Independent Risk Factors for Frailty: A Retrospective StudySemantic proximity Read ↗

Lower serum level of miRNA-21 may be considered as a comorbidity-independent characteristic of frailty in cardiovascular patientsSemantic proximity Read ↗

Analysis of Plasma MicroRNAs as Predictors and Biomarkers of Aging and Frailty in HumansSemantic proximity Read ↗

Circulating miRNAs Associated with Frailty in Old People with Cardiovascular Diseases Promote Cellular Senescence and InflammationSemantic proximity Read ↗

Frailty biomarkers in humans and rodents: Current approaches and future advancesSemantic proximity Read ↗

Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseasesSemantic proximity Read ↗

Frailty and Biological AgeSemantic proximity Read ↗

Frailty in older persons: multisystem risk factors and the Frailty Risk Index (FRI).Semantic proximity Read ↗

Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults.Semantic proximity Read ↗

A Multi-Dataset Transcriptomic Analysis Unravels Core Mechanisms Involving Vitamin D Metabolism and Inflammatory Pathways for Frailty DiagnosisSemantic proximity Read ↗

Novel proteomic subtypes of frailty with distinct molecular patterns and prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.